<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02507726</url>
  </required_header>
  <id_info>
    <org_study_id>OPM-G-H-1501</org_study_id>
    <nct_id>NCT02507726</nct_id>
  </id_info>
  <brief_title>Multicenter and Open Pilot Clinical Study on the Safety of a New One-piece Convex Appliance in Patients With Enterostomy</brief_title>
  <official_title>Multicenter and Open Pilot Clinical Study on the Safety of a New One-piece Convex Appliance in Patients With Enterostomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>BBraun Medical SAS</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>BBraun Medical SAS</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the performance of a new 1-piece ostomy convex appliance in patients&#xD;
      with enterostomy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary outcome Measure:&#xD;
&#xD;
      To describe Investigational Device performance in term of level of leakage under the skin&#xD;
      protector&#xD;
&#xD;
      Secondary Outcome Measure:&#xD;
&#xD;
        -  Assessment of the condition of peristomal skin&#xD;
&#xD;
        -  Assessment of other performance criteria&#xD;
&#xD;
        -  Assessment of AEs for each patient&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Flexima® Active Soft Convex ostomy appliance performance description in term of level of leakage under the skin protector</measure>
    <time_frame>14 +- 3 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Peristomal skin evaluation with DET score scale</measure>
    <time_frame>baseline and 14 +- 3 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with Adverse Events as a Measure of Safety and Tolerability</measure>
    <time_frame>baseline and 14 +- 3 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Investigational product wear time</measure>
    <time_frame>14 +- 3 days</time_frame>
    <description>The patient will complete his patient diary after each Investigational Product removal</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Investigational product adhesivity as measured by a Likert scale score (1-4)</measure>
    <time_frame>14 +- 3 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Investigational product flexibility as measured by a Likert scale score (1-4)</measure>
    <time_frame>14 +- 3 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Investigational product conformability as measured by a Likert scale score (1-4)</measure>
    <time_frame>14 +- 3 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Convex ring suppleness of the Investigational product as measured by a Likert scale score (1-4)</measure>
    <time_frame>14 +- 3 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Connection of the Investigational Product belt to the belt hear as measured by a Likert scale score (1-4)</measure>
    <time_frame>14 +- 3 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Residues on the skin after each Investigational Product removal as measured by a Likert scale score (1-4)</measure>
    <time_frame>14 +- 3 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ease of Investigational Product handling as measured by a Likert scale score (1-4)</measure>
    <time_frame>14 +- 3 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Investigational Product wearing comfort as measured by a Likert scale score (1-4)</measure>
    <time_frame>14 +- 3 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Investigational Product leakage prevention as measured by a Likert scale score (1-4)</measure>
    <time_frame>14 +- 3 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Feeling of Investigational Product security as measured by a Likert scale score (1-4)</measure>
    <time_frame>14 +- 3 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Investigational Product overall satisfaction as measured by a Likert scale score (1-4)</measure>
    <time_frame>14 +- 3 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of Investigational Product in the future as measured by a Likert scale score (1-2)</measure>
    <time_frame>14 +- 3 days</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Enterostomy</condition>
  <arm_group>
    <arm_group_label>Flexima Active Soft convexe</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Flexima Active soft convexe (1 to 3 appliances per day)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Flexima Active soft convexe</intervention_name>
    <description>The Investigational Device will be used during 14 +- 3 days.</description>
    <arm_group_label>Flexima Active Soft convexe</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patient is at least 18 years old,&#xD;
&#xD;
          -  patient having a colostomy or an ileostomy for at least 1 month,&#xD;
&#xD;
          -  patient having a stoma's diameter inferior to 45 mm,&#xD;
&#xD;
          -  patient having a flat or flushed or slightly retracted stoma,&#xD;
&#xD;
          -  patient using currently a one-piece soft convex or standard ostomy appliance with&#xD;
             closed or drainable bags,&#xD;
&#xD;
          -  patient using a minimum of 1 product per day with closed pouches or minimum 1 product&#xD;
             per two days with drainable pouches&#xD;
&#xD;
          -  patient capable to apply and remove the pouch himself or with the help of a caregiver&#xD;
             (except health care professional)&#xD;
&#xD;
          -  patient having a mental capacity to participate to the study (i.e. to understand the&#xD;
             study and to answer to the questions)&#xD;
&#xD;
          -  patient agreeing to test investigational product during 14(±3) days.&#xD;
&#xD;
          -  patient covered by social security&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patient experiencing repeated leakages with his current appliance,&#xD;
&#xD;
          -  patient receiving or having received, within the last month, chemotherapy or&#xD;
             radiotherapy or corticotherapy,&#xD;
&#xD;
          -  patient having a deeply retracted stoma,&#xD;
&#xD;
          -  patient currently suffering from peristomal skin complications (bleeding or severe&#xD;
             irritation or red and broken skin at the time of inclusion),&#xD;
&#xD;
          -  patient already participating in another clinical study or who have previously&#xD;
             participated in this investigation,&#xD;
&#xD;
          -  pregnant or breast-feeding woman&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrick RAT, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Dijon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Patrick RAT</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <study_first_submitted>July 3, 2015</study_first_submitted>
  <study_first_submitted_qc>July 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 24, 2015</study_first_posted>
  <last_update_submitted>September 22, 2016</last_update_submitted>
  <last_update_submitted_qc>September 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 23, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

